Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Journal of Clinical Pharmacology|November 18, 2020
Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and SimulationYoko Franchetti, Thomas D NolinThe Journal of Pharmacology and Experimental Therapeutics|August 11, 2019
Simultaneous Assessment of Hepatic Transport and Metabolism Pathways with a Single Probe Using Individualized PBPK Modeling of 14CO2 Production Rate DataYoko Franchetti, Thomas D NolinJournal of Clinical Pharmacology|January 18, 2021
Application of Individualized PBPK Modeling of Rate Data to Evaluate the Effect of Hemodialysis on Nonrenal Clearance PathwaysYoko Franchetti, Thomas D NolinJournal of Clinical Pharmacology|October 21, 2021
Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical EquationsYoko FranchettiBMC Public Health|April 11, 2014
Socio-demographic and lifestyle factors for child's physical growth and adiposity rebound of Japanese children: a longitudinal study of the 21st century longitudinal survey in newbornsYoko Franchetti, Hiroo IdeCurrent Opinion in Nephrology and Hypertension|October 23, 2008
Altered nonrenal drug clearance in ESRDThomas D NolinSeminars in Dialysis|April 10, 2015
A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKDThomas D NolinClinical Journal of the American Society of Nephrology : CJASN|January 23, 2019
Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance HemodialysisJason R Stubbs, Margaret R Stedman, Sai Liu, et al.Handbook of Experimental Pharmacology|December 19, 2009
Mechanisms of drug-induced nephrotoxicityThomas D Nolin, Jonathan HimmelfarbJournal of Biopharmaceutical Statistics|August 21, 2013
An adaptive two-stage dose-response design method for establishing proof of conceptYoko Franchetti, Stewart J Anderson, Allan R SampsonPageof 15